Abstract Epilepsy is a common chronic neurological disorder in pediatric age characterized by recurrent, unprovoked seizures; these seizures are transient signs of abnormal excessive or hyper synchronous neuronal activity in the brain. Complicated epilepsy is associated with high seizure frequency, prolonged seizures and may lead to some sort of cardiac ischemia, myocardial injury and elevated serum CTnI. Aim: A possible importance of Cardiac troponin I (CTnI) level in epileptic children. Patients and methods: The study was carried out upon 90 children, classified into three groups: Group I: 30 with uncomplicated epilepsy. Group II: 30 with complicated epilepsy. Group III (control): 30 apparently clinically healthy children with similar age and sex. All groups were subjected to the following: full history taking -thorough clinical examination -EEG -assessment of serum cardiac troponin I-and CT only for groups I and II. Results: Our research revealed a significant statistical increase in the cardiac troponin level (CTnI) maximum in group II followed by group I then lastly group III and revealed a direct correlation between cardiac troponin I and presence of prenatal problem, mental retardation, EEG abnormality and abnormal C T or MRI. There was an indirect correlation between cardiac troponin I and age of seizure onset. Also there was one between cardiac troponin I and etiology of epilepsy. Conclusion: Cardiac troponin I is a perfect tool for early detection of cases with myocardial dysfunction in epileptic patients -cardiac troponin I is significantly increased in children with epilepsy especially the complicated epilepsy. Cardiac injury in epileptic children is more common in patients with early onset epilepsy, positive prenatal problem, idiopathic epilepsy, abnormal imaging and EEG -elevated TnI levels may be of value in assessing the severity and eventual outcome and mortality risk of the disease in children with epilepsy.
Introduction
Epilepsy is one of the most common and challenging neurological disorders affecting children. The cumulative life time incidence of epilepsy is now considered to be 3% where more than half of the cases begin in childhood. 1 Epilepsy has been defined as recurrent convulsive and non convulsive seizures caused by partial or generalized epileptogenic discharge in the cerebrum. 2 An epileptic seizure is the result of temporary physiologic dysfunction of the brain caused by a self-limited abnormal, hypersynchronous electrical discharge from cortical neurons. 3 Epilepsy has been proved to cause neurodegeneration and progressive brain damage, neuroprotection seems to play a crucial role in the management of the disease. 4 Cardiac troponin I (CTnI) is a myofibrillar protein regulating the interaction of actin and myosin. It is 100% tissue specific for the heart and is an excellent serum marker for detecting myocardial injury. Cardiac troponin I (CTnI) is released into the circulation in response to ischemic and non-ischemic cardiac injury. Concentrations of both troponin begin to rise in the 4-8 h following injury and peak at 12-24 h. Cardiac troponin T may remain raised for more than two weeks and CTnI for more than 5-7 days. 5 Based on previous studies, contradictory results have been reported about elevation of serum levels of CTnI in patients presenting with sub-acute or acute neurological disorders with or without seizures. 6 
Aim of the work
Study of serum Cardiac troponin I (CTnI) level as a biomarker for cardiac injury in epileptic children.
Patients and methods
The present study was conducted on 90 children (60 epileptic patients, 30 apparently healthy children as control) divided into 46 boys and 44 girls aged from 4 month to 17 years attending the pediatric outpatient neurology clinic, Menofiya University, during the period from January to June 2012. The diagnosis of epilepsy was based on history, clinical examination, and Electroencephalogram. The study compromised 60 epileptic patients with the following inclusion criteria: both sexes are included -known patients of epilepsy -patients with history of an attack of seizure during last week.
The exclusion criteria for the study: patients with single unprovoked seizure -cardiac patients -patients with other diseases or illnesses that might affect CVS (cardio vascular system) & ANS (autonomic nervous system), e.g. SLE, endocrinal and metabolic disorders -patients on any regular medication, other than the antiepileptic drugs, that might affect CVS and ANS -patients with acute illness till cured.
All children in the study were further classified to three groups:
Group I: Included 30 children diagnosed with uncomplicated epilepsy, (epilepsy with no neurological abnormality except seizures) they were randomly selected, their age ranged from 4 months to 17 years (with mean age 6 ± 3.41 years), 12 males and 18 females. (The selected patients were initially assessed.) Group II: Included 30 children diagnosed with complicated epilepsy, (epilepsy associated with abnormal neurological examination) they were randomly selected, their age ranged from 4 month to 17 years (with mean age 4.63 ± 4.32 years), 16 males and 14 females. (The selected patients were initially assessed.) Group III (control group): 30 apparently clinically healthy children, they were randomly selected, their age ranged from 4 month to 17 years (with mean age 6.32 ± 4.11 years), 15 males and 15 females, matching the patients in their age, sex. They were selected from the same population and age groups to which the patient belonged with no history suggesting epilepsy or other medical, metabolic, neurological or psychiatric disorders. There was a statistically significant difference between the studied groups regarding the EEG findings -there was no statistically significant difference between the studied groups regarding the types of EEG abnormality, site of focal activity. * Significant. ** Highly significant. There was a statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) among all studied groups. * Significant. ** Highly significant. There was a statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to the onset of seizures. * Significant. ** Highly significant. There was a statistically significant difference between the studied groups regarding the cardiac troponin level(CTnI) in relation to the prenatal problem. * Significant. ** Highly significant. There was a statistically significant difference between the studied groups regarding the cardiac troponin level(CTnI) in relation to etiology. * Significant. ** Highly significant.
Methodology
After approval of the ethics committee, informed consents were obtained from the parents of the selected children and from adolescent patients. All the selected patients were subjected to the following: 
Results
Results are shown in Tables 1-7 and Figs. 1-3.
Discussion
Electroencephalogram (EEG) plays a central role in the diagnosis and management of patients with seizure disorders, because it is a convenient and relatively inexpensive way to demonstrate the physiological manifestations of abnormal cortical excitability that underlie epilepsy. Normal EEG does not exclude epilepsy as around 10% of patients with epilepsy never show epileptiform discharge. Because epilepsy is an intermittent and unpredictable disorder, most EEGs in patients with seizures are obtained between rather than during attacks. Patients who are taking an anticonvulsant and who are scheduled for a routine EEG should not decrease or discontinue the medication before the study. 7 In the study there was a significant difference regarding the EEG abnormalities. About 60% of patients in group I (uncomplicated epilepsy) and 30% in group II (complicated epilepsy) had normal EEG. Similar results were obtained by Andrade et al. 8 who show that normal EEG does not exclude the diagnosis of epilepsy because interictal recording is normal in approximately 40% of patients. Abnormal EEG had been detected in 70% of patients in group II (complicated epilepsy) and 40.0% in group I (uncomplicated epilepsy). EEG There was a statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to normal neuro imaging. There was no statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to abnormal neuroimaging. * Significant. ** Highly significant. There was a statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to EEG. * Significant. ** Highly significant.
abnormalities were in the form of diffuse slowing in 64.6% in group II (complicated epilepsy) and 16.6% in group I (uncomplicated epilepsy) These agrees with finding by Andrade et al. 8 who stated that most of the patients with symptomatic epilepsy had abnormal EEG. Cardiac troponin I was elevated in about 30% of patients in group I (uncomplicated epilepsy), while in group II (complicated epilepsy) 83.3% had elevated cardiac troponin I ''CTnI''. Similar results were obtained by Colugnati et al. 13 In contrast to current results, Hajsadeghi et al. 9 had shown that the serum troponin level was not higher than the normal range in both groups of patients though it was significantly higher in the group of patients with complicated seizures when compared to the uncomplicated group. Del Rey et al. 10 had attributed higher troponin I levels in complicated patients to the negligible injury of cardiac tissue during seizure.
In the present study there was a significant difference regarding the level of cardiac troponin I ''CTnI'' in relation to the age of onset of seizures (p < 0.05), where eight out of nine patients (88.9%) in group II (complicated epilepsy) with onset of seizures at neonatal period had abnormal cardiac troponin I ''CTnI'' level. While thirteen patients out of fifteen patients (86.7%) in group II (complicated epilepsy) with onset of seizures during infancy had abnormal cardiac troponin I ''CTnI'' level. At the childhood period, four out of six patients (66.7%) in group II (complicated epilepsy) had abnormal cardiac troponin I ''CTnI'' level.
In concordance to current results Hajsadeghi et al. 9 stated that a considerable increase in CTnI indicates seriously affected myocardium in hypoxic newborn and that re-oxygenation with 100% oxygen offered no biochemical benefit over ambient air.
Within the present study, there was a significant relation of cardiac troponin I ''CTnI'' level and prenatal problem (p < 0.01, 0.05). Within group II (complicated epilepsy), there was a significant correlation within the seventeen patients with prenatal problems where thirteen out of seventeen patients (76.5%) had positive abnormal cardiac troponin I ''CTnI'' level. The same results were obtained by a study done by Chaiworapongsa et al. 11 , who found that troponin I was marginally elevated in their cases who were neonates of preeclamptic mothers and they attributed this to a mild degree of myocardial injury allowing them to survive.
In neonates, cardiac troponins T (cTnT) and I (CTnI) have been shown to identify myocardial injury in asphyxia Moller et al. 12 . In the current study there was a significant correlation between the level of cardiac troponin I and etiology of epilepsy (p < 0.01). In the group with idiopathic epilepsy nine patients out of ten (90%) and sixteen patients out of 20 (80%) in the group with secondary epilepsy in group II (complicated epilepsy) had abnormal cardiac troponin I ''CTnI'' level. Patients with abnormal neurological examination usually experience more severe and frequent epileptic fits which are usually resistant and intractable to treatment which may expose these patients to some sort of cardiac ischemia, and so it is thought that the more severe and frequent the attacks, the more will be the risk of cardiac ischemia, so we recommend regular follow up with cardiac troponin I for early detection of cardiac ischemia especially in patients with severe neurological deficits.
Within the study groups, there was a statistically significant difference between the cardiac troponin level (CTnI) in relation to neuro imaging (p < 0.01, 0.05). In addition there was a statistically significant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to EEG (p < 0.01).
Conclusion
Cardiac troponin I is a perfect tool for early detection of cases with myocardial dysfunction in epileptic patients. Cardiac troponin I is significantly increased in children with epilepsy especially the complicated epilepsy. Cardiac injury in epileptic children is more common in patients with early onset epilepsy, in patients with positive prenatal problem, idiopathic epilepsy and mentally retarded who have abnormal imaging and EEG. Elevated TnI levels may be of value in assessing the severity, eventual outcome and mortality risk of the disease in children with epilepsy.
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